Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-27T19:35:08.112Z Has data issue: false hasContentIssue false
  • English
  • Français

Patient Confidentiality and the Surrogate's Right to Know

Published online by Cambridge University Press:  01 January 2021

Lynn A. Jansen  and
Lainie Friedman Ross
Get access Rights & Permissions [Opens in a new window]

Extract

Physicians treating newly incapacitated patients often must navigate surrogate decision-makers through a difficult course of treatment decisions. Such a process can be complex. Physicians must not only explain the medical facts and prognosis to the surrogate, but also attempt to ensure that the surrogate arrives at decisions that are consistent with the patient's own values and wishes. Where these values and wishes are unknown, physicians must help surrogates make decisions that reflect the patient's best interests.

Type
Article
Information
Journal of Law, Medicine & Ethics , Volume 28 , Issue 2 , Summer 2000 , pp. 137 - 143
Copyright
Copyright © American Society of Law, Medicine and Ethics 2000

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Buchanan, A.E. and Brock, D.W., Deciding for Others; The Ethics of Surrogate Decision-Making (Cambridge, MA: Cambridge University Press, 1990).CrossRefGoogle Scholar
See Buchanan, supra note 1.Google Scholar
Lieberson, A.D., Advance Medical Directives, Cumulative Supplement. (West Group Publishing, July 1999).Google Scholar
Rich, B., “Advance Directives: The Next Generation,” Journal of Legal Medicine, 10 (1998): 1–20.Google Scholar
Beauchamp, T.O. and Childress, J.F., Principles of Biomedical Ethics, 4th edition (New York: Oxford University Press, 1994): at 127.Google Scholar
Katz, J., The Silent World of Doctor and Patient (New York: The Free Press, 1984).Google Scholar
Meisel, A. and Kuczewski, M., “Legal and Ethical Myths about Informed Consent,” Archives of Internal Medicine, 156 (1996): 2521–2526.Google Scholar
See Meisel, supra note 7.Google Scholar
King, M.B. “For Debate: AIDS on the Death Certificate: The Final Stigma,” British Medical Journal, 298 (1989): 734–736. See also Redelmeier, D.A., “Public Access to Death Certificates,” Annals of Intern Medicine, 111 (1989) at 92; Kawakami T., “HIV and Sports: What Have We Learned? “A Difficult Lesson: ‘Decision on whether it was proper to report on Ashe's medical condition remains an important topic of discussion for the media, observers,’” Los Angeles Times, November 3, 1996, at C–10.CrossRefGoogle Scholar
Superintendent of Belchertown State School v. Saikewicz, 370 N.E. 2d 417 (1977).Google Scholar
Ad Hoc Committee on AIDS Policy. AIDS Policy: Confidentiality and Disclosure. American Journal of Psychiatry, 145 (1988): 541.Google Scholar
Stein, B., and Samet, J.H., “Disclosure of HIV Status,” AIDS Patient Care, 13 (1999): 265–267. See also Bayer, R., “Public Health Policy and the AIDS Epidemic: An End to HIV Exceptionalism?” N. Engl. J. Med., 324 (1991): 1500–1504.Google Scholar
See Beauchamp, and Childress, supra note 5.Google Scholar
Tarasoff v. Regents of the University of California, 17 Cal.3rd. 425 (1976).Google Scholar
Siegler, M., “Confidentiality in Medicine; A Decrepit Concept,” N. Engl. J. Med., 302 (1982): 1518–1521.CrossRefGoogle Scholar
Mansergh, G. Marks, G., and Simoni, J.M., “Self-Disclosure of HIV Infection Among Men Who Vary in Time Since Sero-Positive Diagnosis and Symptom Status,” AIDS, 9 (1995) 639–644. See also Wolitski, R.J. et al., “HIV Serostatus Disclosure Among Gay and Bisexual Men in Four American Cities: General Patterns and Relations to Sexual Practices,” AIDS Care, 10 (1998): 599–610. See also Holt, R. et al., “The Role of Disclosure in Coping with HIV Infection,” AIDS Care, 10 (1998): 49–60; Levy, A. et al., “Disclosure of Seropositivity,” Journal of Clinical Psychology 55 (1999): 1041–1049.Google Scholar
The Illinois Healthcare Surrogate Act as amended by PA 90–246. (1999).Google Scholar
See Lieberson, supra note 3.Google Scholar
Cox, D.M. and Sacks, G. “Advance Directives and The Patient Self-Determination Act,” Clinics of Geriatric Medicine, 10 (1994): 431–443.Google Scholar
See Mansergh, supra note 16. See also Teno, J. et al., “The Formal Use of Advance Directives Among Patients with HIV-related Disease,” Journal of General Internal Medicine, 5 (1990): 490–494. See also Steinbrook, R. et al., “Preferences of Homosexual Men with AIDS for Life-sustaining Treatment,” N. Engl. J. Med., 325 (1986): 457–460; Kohut, N. et al., “Stability of Treatment Preferences: Although Most Preferences Do Not Change, Most People Change Some of Their Preferences,” Journal of Clinical Ethics, 8 (1987): 124–135.Google Scholar
Wolf, S.M. et al., “Sources of Concern about the Patient Self-Determination Act,” N. Engl. J. Med., 325 (1991): 1661–1671.CrossRefGoogle Scholar
Singer, P.A., “Disease-Specific Advance Directives,” The Lancet, 344 (1994): 594–596. See also Singer, P.A. et al., “The HIV-Specific Advance Directive,” Journal of General Internal Medicine, 12 (1997): 729–735.Google Scholar
See Singer, P.A. et al., (1997), supra note 22.Google Scholar
Wilson, I.B., “End of Life Care in HIV Disease: Let's Talk,” Journal of General Internal Medicine, 12 (1997): 784–786.CrossRefGoogle Scholar
Lambert, P. Gilbert, J.M., and Nathanson, P., “The Values History: An Innovation in Surrogate Medical Decision Making,” Law, Medicine & Health Care, 18 (1990); 202–212. See also Doukas, D.J. and McCullough, L.B., “The Values History: The Evaluation of the Patient's Values and Advance Directives,” Journal of Family Practice 32 (1991): 145–153.CrossRefGoogle Scholar
See Mansergh, supra note 16. See also Wolitski, supra note 16.Google Scholar
See Steinbrook, et al., supra note 20. See also Kohut, et al., supra note 20.Google Scholar
See Kohut, et al., supra note 20.Google Scholar